| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―04 |
Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach |
Noor Atatreh, Lana Bustanji, Juliana Ferreira, Wael Rabeh, Radwa Mahgoub, Mohammad Ghattas |
| 2 |
[GO] |
2025―Aug―26 |
Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects |
Duo Lv, Sichan Li, Yi Li, Meihua Lin, You Zhai, Meijia Wu, et al. (+3) Yunqing Qiu, Qingwei Zhao, Jian Liu |
| 3 |
[GO] |
2025―Jun―09 |
Development and Validation of a UPLC-MS/MS Detection Method of Baricitinib for Therapeutic Drug Monitoring in COVID-19 Patients |
Ruanjuan Zhan, Yuxin Shen, Haoxin Fu, Hualu Wu, Xiaohai Chen, Yige Yu, Ren-Ai Xu |
| 4 |
[GO] |
2025―May―15 |
Design and Evaluation of Andrographolide Analogues as SARS-CoV-2 Main Protease Inhibitors: Molecular Modeling and in vitro Studies |
Utid Suriya, Pansachon Intamalee, Rungnapha Saeeng, Patcharin Wilasluck, Peerapon Deetanya, Kittikhun Wangkanont, et al. (+3) Phongthon Kanjanasirirat, Chanikarn Wongwitayasombat, Bodee Nutho |
| 5 |
[GO] |
2024―Dec―02 |
Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection |
Runcong Zhang, Jing Fan, Lu Han, Juehui Mao, Liang Sun, Yuetian Yu, et al. (+4) Weibin Fan, Jiao Xie, Bin Lin, Nengming Lin |
| 6 |
[GO] |
2024―Sep―20 |
Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches |
Ali Attiq, Sheryar Afzal, Habibah Wahab, Waqas Ahmad, Mahmoud Kandeel, Yassir Almofti, et al. (+2) Ahmed Alameen, Yuan Seng Wu |
| 7 |
[GO] |
2024―May―29 |
Neurovascular Adverse Effects of Sars-Cov-2 Vaccination |
Leonidas Panos, Panagiotis Bargiotas, Georgios Hadjigeorgiou, Georgios Panos |
| 8 |
[GO] |
2023―Jan―19 |
The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19 |
Shih-Lung Cheng, Ping-Huai Wang, Cheng-Yu Chang, Hsu-Hui Wang, Chung-Jen Wang, Kuan-Ming Chiu |
| 9 |
[GO] |
2022―Oct―18 |
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study |
Vincenzo Spagnuolo, Marta Voarino, Marco Tonelli, Laura Galli, Andrea Poli, Elena Bruzzesi, et al. (+10) Sara Racca, Nicola Clementi, Chiara Oltolini, Moreno Tresoldi, Patrizia Rovere Querini, Lorenzo Dagna, Alberto Zangrillo, Fabio Ciceri, Massimo Clementi, Antonella Castagna |
| 10 |
[GO] |
2022―Sep―08 |
Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach |
Heba Abdel-Halim, Malak Hajar, Luma Hasouneh, Suzanne M A Abdelmalek |
| 11 |
[GO] |
2022―Aug―02 |
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents |
Lara Alzyoud, Mohammad A Ghattas, Noor Atatreh |
| 12 |
[GO] |
2022―Jul―11 |
Recent Progress in the Development of Opaganib for the Treatment of Covid-19 |
Charles D Smith, Lynn W Maines, Staci N Keller, Vered Katz Ben-Yair, Reza Fathi, Terry F Plasse, Mark L Levitt |
| 13 |
[GO] |
2022―Apr―08 |
Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds |
Jiajie Zhu, Haiyan Zhang, Qinghong Lin, Jingting Lyu, Lu Lu, Hanxi Chen, et al. (+3) Xuning Zhang, Yanjun Zhang, Keda Chen |
| 14 |
[GO] |
2022―Mar―30 |
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19? |
Xuesong He, Xiao Xue Zeng |
| 15 |
[GO] |
2022―Mar―24 |
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir |
Santiago Moreno, Bernardino Alcázar-Navarrete, Carlos Dueñas, Juan González del Castillo, Julián Olalla, Antonio Antela |
| 16 |
[GO] |
2022―Mar―14 |
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval |
Nada A Ashour, Ayman Abo Elmaaty, Amany A Sarhan, Eslam B Elkaeed, Ahmed M Moussa, Ibrahim Ali Erfan, Ahmed A Al-Karmalawy |
| 17 |
[GO] |
2021―Oct―27 |
An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection |
Sabrina Bimonte, Cira Antonietta Forte, Massimiliano Cuomo, Gennaro Esposito, Marco Cascella, Arturo Cuomo |
| 18 |
[GO] |
2021―Aug―25 |
Role of Folate, Cobalamin, and Probiotics in COVID-19 Disease Management [Letter] |
Dayab Asad, Syed Hasan Shuja |
| 19 |
[GO] |
2021―Jul―29 |
COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach |
Soha R Abd El Hadi, Esmat E Zien El-Deen, Mostafa M Bahaa, Abdelfattah A Sadakah, Heba A Yassin |
| 20 |
[GO] |
2021―May―02 |
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure |
Osama Badary, Marwa S Hamza, Rajiv Tikamdas |
| 21 |
[GO] |
2021―Mar―28 |
Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19 |
Chenghai Li, Hua Zhao, Linna Cheng, Bin Wang |
| 22 |
[GO] |
2021―Mar―10 |
Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model |
Acharya Balkrishna, Subarna Pokhrel, Hoshiyar Singh, Monali Joshi, Vallabh Prakash Mulay, Swati Haldar, Anurag Varshney |
| 23 |
[GO] |
2021―Mar―03 |
Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic |
Shenqi Zhang, Chengbin Wang, Lei Shi, Qingyun Xue |
| 24 |
[GO] |
2020―Dec―30 |
Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review |
Yahdiana Harahap, Rasmina Diptasaadya, Denni Joko Purwanto |
| 25 |
[GO] |
2020―Nov―18 |
COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis |
Bin Wang, Junkai Lai, Xiaoyan Yan, Feifei Jin, Bin Yi, Caixia An, et al. (+2) Yuanxiao Li, Chen Yao |
| 26 |
[GO] |
2020―Nov―17 |
Repurposing Anti-Cancer Drugs for COVID-19 Treatment |
Nicholas Borcherding, Yogesh Jethava, Praveen Vikas |
| 27 |
[GO] |
2020―Sep―29 |
Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19 |
Chenghai Li, Hua Zhao, Bin Wang |
| 28 |
[GO] |
2020―Sep―17 |
Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19 |
Weilong Zhang, Yinghua Lv, Juan Yang, Yunhui Chen, Yingchun He, Jihan Huang |
| 29 |
[GO] |
2020―Aug―20 |
A Single Large Dose of Vitamin D Could be Used as a Means of Coronavirus Disease 2019 Prevention and Treatment |
Guoqiang Liu, Tianpei Hong, Jin Yang |
| 30 |
[GO] |
2020―Aug―05 |
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19 |
Seyed MohammadReza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati |
| 31 |
[GO] |
2020―Jul―27 |
Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients |
Lu Li, Xiaojuan Wang, Rongrong Wang, Yunzhen Hu, Saiping Jiang, Xiaoyang Lu |
| 32 |
[GO] |
2020―Jul―05 |
Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19 |
Amin Sedokani, Sadegh Feizollahzadeh |
| 33 |
[GO] |
2020―May―28 |
Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov |
Jihan Huang, Yingchun He, Qianmin Su, Juan Yang |
